| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'10 |
|---|---|---|---|---|---|---|---|---|
Net sales | ||||||||
- | - | - | - | - | - | - | 0 | - |
Licensing revenue | ||||||||
- | - | - | - | - | - | - | 0 | - |
Grant revenue | ||||||||
- | - | - | - | - | - | - | 0 | 488 |
Grant and award revenue | ||||||||
- | - | - | 400 | 54 | 0 | 0 | 0 | 488 |
Cost of goods sold | ||||||||
- | - | - | - | - | - | - | 0 | - |
Gross margin | ||||||||
- | - | - | - | - | - | - | 0 | 488 |
Operating expenses: | ||||||||
Research and development | ||||||||
38,781 | 37,173 | 18,512 | 8,182 | 4,321 | 19,435 | 12,902 | 8,088 | 3,688 |
General and administrative | ||||||||
13,081 | 10,654 | 11,081 | 2,820 | 1,650 | - | - | - | - |
Impairment of acquired IPR&D | ||||||||
- | 21,692 | - | - | - | - | - | - | - |
Write-off of in-process research and development | ||||||||
- | - | - | - | - | - | - | 0 | - |
Impairment of goodwill | ||||||||
26,852 | - | - | - | - | - | - | 0 | - |
Depreciation | ||||||||
311 | 526 | 363 | 346 | 6 | - | - | - | - |
Selling, general and administrative | ||||||||
- | - | - | - | - | 9,488 | 8,518 | 7,519 | 4,989 |
Transaction-related expenses | ||||||||
- | - | - | - | - | 271 | 79 | -69 | - |
Transaction-related expenses | ||||||||
- | - | - | - | - | - | - | - | -330 |
Depreciation and amortization | ||||||||
- | - | - | - | - | 85 | 40 | 90 | 19 |
Equity in loss of investee | ||||||||
- | - | - | - | - | - | - | 0 | - |
Total operating expenses | ||||||||
79,025 | 70,045 | 29,956 | 11,348 | 5,977 | 29,279 | 21,539 | 15,628 | 9,028 |
Loss from operations | ||||||||
-79,025 | -70,045 | -29,956 | -10,948 | -5,923 | -29,279 | -21,539 | -15,628 | -8,539 |
Other income, net: | ||||||||
Interest expense, net | ||||||||
-70 | 11 | -1,161 | - | - | - | - | - | - |
Reduction of fair value of warrants | ||||||||
- | - | - | - | - | - | - | 0 | - |
Interest income | ||||||||
- | - | - | - | - | 69 | 60 | 73 | 92 |
Interest expense, net | ||||||||
- | - | - | 452 | 2,585 | - | - | 0 | 1 |
Foreign currency exchange gain (loss) | ||||||||
- | - | - | 76 | - | - | - | - | - |
Foreign currency exchange gain (loss) | ||||||||
-78 | 71 | -218 | - | - | - | - | - | - |
Tax credit income | ||||||||
1,213 | 1,454 | - | - | - | - | - | - | - |
Loss on extinguishment of debt | ||||||||
- | - | -1,816 | - | -226 | - | - | - | - |
Change in fair value of financial instruments | ||||||||
-213 | -64 | -280 | 44 | -265 | - | - | - | - |
Total other income | ||||||||
852 | 1,472 | -3,475 | -332 | -3,076 | 508 | -1 | -5 | -2 |
Loss before income taxes | ||||||||
-78,173 | -68,573 | -33,431 | -11,280 | -8,999 | -28,702 | - | - | - |
Income tax benefit | ||||||||
- | -7,057 | -3,634 | -357 | - | 0 | - | - | - |
Loss before cumulative effect of change in accounting principle | ||||||||
- | - | - | - | - | - | - | -15,559 | -8,450 |
Cumulative effect of change in accounting principle | ||||||||
- | - | - | - | - | - | - | 0 | - |
Net loss | ||||||||
-78,173 | -61,516 | -29,797 | -10,923 | -8,999 | -28,702 | -21,480 | -15,559 | -8,450 |
Accretion of redeemable convertible preferred stock | ||||||||
- | - | 578 | 94 | 183 | - | - | - | - |
Deemed dividend on beneficial conversion feature | ||||||||
- | - | 404 | - | - | - | - | - | - |
Preferred stock dividends | ||||||||
- | - | - | - | - | - | - | 0 | - |
Deemed dividends on preferred stock | ||||||||
- | - | - | - | - | - | - | 0 | 5,639 |
Net loss attributable to common stockholders | ||||||||
- | - | -30,779 | -11,017 | -9,182 | - | - | -15,559 | -14,090 |
Net loss per share: | ||||||||
Basic and diluted | ||||||||
-1.95 | -1.85 | -1.76 | -5.62 | -9.48 | -0.23 | -0.28 | -0.33 | -1.07 |
Weighted average common shares outstanding: | ||||||||
Basic and diluted | ||||||||
40,027 | 33,300 | 17,521 | 1,960 | 968 | 122,409 | 76,585 | 47,641 | - |
Other comprehensive loss: | ||||||||
Loss on foreign currency translation | ||||||||
-296 | -773 | 1,595 | -591 | - | - | - | 0 | - |
Weighted average shares outstanding - basic and diluted | ||||||||
- | - | - | - | - | - | - | - | 13,180 |
Net loss | ||||||||
-78,173 | -61,516 | -29,797 | -10,923 | -8,999 | -28,702 | -21,480 | -15,559 | -8,450 |
Other comprehensive (loss)/income | ||||||||
- | - | - | - | - | -4 | -19 | - | - |
Unrealized gain on short-term investments | ||||||||
79 | 15 | -46 | - | - | - | - | 0 | - |
Net loss applicable to common stock | ||||||||
- | - | -30,779 | -11,017 | -9,182 | - | - | - | -14,090 |
Total comprehensive loss | ||||||||
-78,390 | -62,274 | -28,248 | -11,514 | -8,999 | -28,706 | -21,499 | -15,559 | - |